Top Markets
Coin of the day
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc.

BSPM
Peringkat dalam Saham #42724
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets... Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. In addition, the company provides prescription pharmaceutical products, including Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. It sells its products through distributors and website that serves as internet-based China Hepatitis Internet Hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Harga Saham
$0.0001
Terakhir disinkronkan: 2026-08-11
Kapitalisasi Pasar
$264.00
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
CN
Perdagangan Biostar Pharmaceuticals, Inc. (BSPM)

Kategori

Harga BSPM dengan kapitalisasi pasar B
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
BSPM
$0.0001
Kapitalisasi pasar dari Biostar Pharmaceuticals, Inc.(BSPM)
Kapitalisasi Pasar: $264.00
Per August 2026, Biostar Pharmaceuticals, Inc. memiliki kapitalisasi pasar sebesar $264.00. Ini menjadikan Biostar Pharmaceuticals, Inc. sebagai perusahaan 42724th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Biostar Pharmaceuticals, Inc. dari 2008 hingga 2026
BSPM dibandingkan dengan 5 teratas stocks paling populer
Harga BSPM Aset B Pasar B Hasil
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$2,055,299 $264.00
$5.426T +2,055,298,683,037.50%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,680,645 $264.00
$4.437T +1,680,645,217,339.39%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,571,025 $264.00
$4.148T +1,571,024,750,840.53%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,387,818 $264.00
$3.664T +1,387,818,418,650.00%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,094,413 $264.00
$2.889T +1,094,412,685,127.27%